Ampio Pharmaceuticals, Inc. (NASDAQ:AMPE)

zzlangerhans (99.78) Submitted: 8/12/2012 12:42:55 AM : Start Price: $2.81 AMPE Score: +28.43

Wow, another Garza/BioMedReports special. With Cleveland Biolabs, that makes two in one day. Of course, I prefer to sweep up the mangled pieces after these high-fliers take their well-deserved plunges from Pumper's Peak. Now that the dilutive financing is out of the way, Ampio is free to employ whatever Seeking Alpha miscreants they please to help them pump their share price back up in time for the next financing. Zertane and Optina are down but not out, so stay tuned more much Ampio-related entertainment in the months and years to come.